Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2.
Conway F, Tonkin J, Valipour A, Pison C, Schumann C, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Skowasch D, Johnson PJ, Slebos DJ, Shah PL; AIRFLOW-2 Trial Study Group.
Conway F, et al. Among authors: lamprecht b.
Respiration. 2022;101(11):1069-1074. doi: 10.1159/000527455. Epub 2022 Oct 27.
Respiration. 2022.
PMID: 36302345
Free article.
Clinical Trial.